AIM
ASMB icon

Assured Investment Management’s Assembly Biosciences ASMB Stock Holding History

Assured Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-528
Closed -$125K – 109
2019
Q1 		$125K Buy
528
+29
+6% +$7.34K ﹤0.01% 869
2018
Q4 		$135K Sell
499
-718
-59% -$208K ﹤0.01% 936
2018
Q3 		$542K Buy
1,217
+610
+100% +$286K 0.01% 734
2018
Q2 		$286K Sell
607
-1,089
-64% -$576K 0.01% 941
2018
Q1 		$1M Buy
+1,696
New +$1.05M 0.02% 545

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Assured Investment Management's ASMB Position: Q2 2019 in Review

Assured Investment Management sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 528 shares — an estimated $125K sold.

Assured Investment Management first reported a position in ASMB in Q1 2018 and held it in 5 quarters. The position peaked at $1M in Q1 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Assured Investment Management reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 528 Assembly Biosciences shares in Q2 2019, an estimated $125K.
  • Assured Investment Management first reported a position in Assembly Biosciences in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Assembly Biosciences position peaked at $1M in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.